Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Prostatic Neoplasms 42Uterine Cervical Neoplasms 41Breast Neoplasms 10Vaginal Neoplasms 6Neoplasms 6Endometrial Neoplasms 6Liver Neoplasms 5Uterine Neoplasms 4Sarcoma 4Lung Neoplasms 4Esophageal Neoplasms 4Vulvar Neoplasms 3Retinoblastoma 3Radiation Injuries 3Ovarian Neoplasms 3Hyperthermia 3Carcinoma, Hepatocellular 3Adenocarcinoma 3Rhabdomyosarcoma 2Rectal Neoplasms 2Melanoma 2Head and Neck Neoplasms 2Gynecologic Cancer 2Desmoplastic Small Round Cell Tumor 2Deglutition Disorders 2Carcinoma, Non-Small-Cell Lung 2Carcinoma, Intraductal, Noninfiltrating 2Carcinoma, Ductal, Breast 2Breast Carcinoma In Situ 2Uveal Melanoma 1

Interventions

linrodostat 1Taxes 1Paclitaxel 1Nivolumab 1Carboplatin 1Brachytherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Endometrial Adenocarcinoma × Brachytherapy × Clear all
NCT01041027 2023-10-26

Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Endometrial Cancer

Albert Einstein College of Medicine

Phase 2 Terminated
31 enrolled 8 charts
Gynecologic

Endometrial Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡